Milap C. Nahata - Search Results

Year	Number of Results
1984	1
2002	5
2003	11
2004	12
2005	13
2006	9
2007	6
2008	6
2009	7
2010	4
2011	5
2012	7
2013	2
2014	4
2015	5
2016	6
2017	4
2018	8
2019	3
2020	6
2021	3
2022	7
2023	13
2024	10
2025	6

1

Nahata MC. Nahata MC. Am J Health Syst Pharm. 2023 Oct 25;80(21):1535-1541. doi: 10.1093/ajhp/zxad160. Am J Health Syst Pharm. 2023. PMID: 37471148 No abstract available.

2

Vonoprazan-based therapies versus PPI-based therapies in patients with H. pylori infection: Systematic review and meta-analyses of randomized controlled trials.

Liu L, Shi H, Shi Y, Wang A, Guo N, Li F, Nahata MC. Liu L, et al. Among authors: nahata mc. Helicobacter. 2024 May-Jun;29(3):e13094. doi: 10.1111/hel.13094. Helicobacter. 2024. PMID: 38790090 Review.

3

Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis.

Liu L, Shi H, Shi Y, Wang A, Guo N, Tao H, Nahata MC. Liu L, et al. Among authors: nahata mc. Pharmaceuticals (Basel). 2024 Jun 24;17(7):828. doi: 10.3390/ph17070828. Pharmaceuticals (Basel). 2024. PMID: 39065679 Free PMC article. Review.

4

Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials.

Liu L, Shi H, Xie M, Sun Y, Nahata MC. Liu L, et al. Among authors: nahata mc. Int J Clin Pharm. 2024 Dec;46(6):1268-1280. doi: 10.1007/s11096-024-01779-x. Epub 2024 Jul 22. Int J Clin Pharm. 2024. PMID: 39037553 Free PMC article. Review.

5

Management of botulism.

Robinson RF, Nahata MC. Robinson RF, et al. Among authors: nahata mc. Ann Pharmacother. 2003 Jan;37(1):127-31. doi: 10.1345/aph.1C034. Ann Pharmacother. 2003. PMID: 12503947 Review.

6

Annals of Pharmacotherapy Celebrating 50 Years: A Story That Keeps Getting Better!

Nahata MC, Sorkin EM. Nahata MC, et al. Ann Pharmacother. 2016 Jan;50(1):5-7. doi: 10.1177/1060028015609189. Ann Pharmacother. 2016. PMID: 26668255 No abstract available.

7

Medication management of irritable bowel syndrome.

Trinkley KE, Nahata MC. Trinkley KE, et al. Among authors: nahata mc. Digestion. 2014;89(4):253-67. doi: 10.1159/000362405. Epub 2014 Jul 2. Digestion. 2014. PMID: 24992947 Review.

8

Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States.

Liu L, Cui J, Neidecker MV, Nahata MC. Liu L, et al. Among authors: nahata mc. J Manag Care Spec Pharm. 2025 May;31(5):441-450. doi: 10.18553/jmcp.2025.31.5.441. J Manag Care Spec Pharm. 2025. PMID: 40298310 Free PMC article.

9

Emerging Opportunities for Pharmacy in Advancing Healthcare.

Nahata MC. Nahata MC. Ann Pharmacother. 2015 Sep;49(9):1075-6. doi: 10.1177/1060028015598586. Epub 2015 Jul 30. Ann Pharmacother. 2015. PMID: 26228935 No abstract available.

10

New indices in scholarship assessment.

Thompson DF, Callen EC, Nahata MC. Thompson DF, et al. Among authors: nahata mc. Am J Pharm Educ. 2009 Oct 1;73(6):111. doi: 10.5688/aj7306111. Am J Pharm Educ. 2009. PMID: 19885080 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Results by year